We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Allergy Therapeutics Plc | LSE:AGY | London | Ordinary Share | GB00B02LCQ05 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.025 | 0.80% | 3.15 | 3.00 | 3.30 | 3.20 | 3.125 | 3.125 | 881,633 | 09:38:55 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 59.59M | -43.07M | -0.0090 | -3.50 | 150.14M |
From Nov 2023 to May 2024
TIDMAGY
RNS Number : 2206Y
AIM
02 January 2024
NOTICE
02/01/2024 7:30am
TEMPORARY SUSPENSION OF TRADING ON AIM
ALLERGY THERAPEUTICS PLC
At the request of the company trading on AIM for the under-mentioned securities has been temporarily suspended from 02/01/2024 7:30am, pending publication of the Company's annual audited accounts.
ORDINARY SHARES OF 0.1P EACH, FULLY PAID
(B02LCQ0) (GB00B02LCQ05)
If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0)20 7886 2500.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
EXCTLBMTMTITBRJ
(END) Dow Jones Newswires
January 02, 2024 02:30 ET (07:30 GMT)
1 Year Allergy Therapeutics Chart |
1 Month Allergy Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
